SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Amrutanjan Healthcare informs about outcome of board meeting

02 Nov 2018 Evaluate

Amrutanjan Healthcare has informed that board of directors of the company at its meeting held today (November 1, 2018) have approved the re-appointment of S Sambhu Prasad as Chairman & Managing Director for a further period of five years from 1st April, 2019 to 31st March, 2024 which is subject to approval of shareholders. The Board has decided to seek the approval of shareholders through Postal Ballot Process for the above re-appointment. Disclosure as required under regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI LODR) is submitted herewith.

The above information is a part of company’s filings submitted to BSE.

Amrutanjan Healthcar Share Price

546.50 7.85 (1.46%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×